Optimizing clinical trials for pediatric obesity treatment

Tag der seltenen Krankheiten: Feier des Fortschritts und Hoffnung für die Zukunft

Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.

Incorporating the voice of patient in pediatric assent forms

SGLT2-Inhibitoren als nierenschützende Agenten für pädiatrische Patienten mit chronischen Nierenerkrankungen

Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection.

Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial

This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.

Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Enrolling adolescents into adult clinical trials

Get insights on bringing safe and effective treatments to children and adolescents sooner.

Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation

Learn about the experiences of the young participants involved in the clinical trials.